No, that’s like saying: Needing stock-pilled masks is a unique situation that nobody could forsee.
There might be another pandemic and we want to be prepared for that. We want companies to invest in being able to produce vaccines on short notice in case of a future pandemic and that won’t happen if it’s not lucrative to be able to produce vaccines on short notice in future pandemics.
Stop investing in future developments, and slowly go out of business?
No, just stop investing in pandemic preparedness (or not start to invest).
Even looking more broadly we also prefer that big pharma invests into research instead of investing into stock buybacks.
Pandemics are generally unique situations. Given what we know at the moment, we would expect similar events to occur perhaps two or three times a century. So developing vaccines specifically for pandemics similar in magnitude to what we are going through right now is not a sound investment to begin with.
No, that’s like saying: Needing stock-pilled masks is a unique situation that nobody could forsee.
There might be another pandemic and we want to be prepared for that. We want companies to invest in being able to produce vaccines on short notice in case of a future pandemic and that won’t happen if it’s not lucrative to be able to produce vaccines on short notice in future pandemics.
No, just stop investing in pandemic preparedness (or not start to invest).
Even looking more broadly we also prefer that big pharma invests into research instead of investing into stock buybacks.
Pandemics are generally unique situations. Given what we know at the moment, we would expect similar events to occur perhaps two or three times a century. So developing vaccines specifically for pandemics similar in magnitude to what we are going through right now is not a sound investment to begin with.